Functional and pharmacological investigation of novel and de novo KCND3 variants identified in patients with neurodevelopmental disorders
- 5 November 2025
- journal article
- research article
- Published by Springer Nature in Journal of Human Genetics
- Vol. 71 (4) , 187-193
Abstract
Sudden unexpected death in epilepsy (SUDEP) is one of the most frequent causes of death in patients with epilepsy, though the pathogenesis of SUDEP has not been well elucidated. Here, we report novel heterozygous KCND3 variants, p.V401L and p.V401M, identified in young patients with refractory epilepsy (RE) and neurodevelopmental disorders, and the functional properties of these variants. We aimed to investigate the electrophysiological changes in de novo KCND3 variants and analyse the pharmacological effects of quinidine on these variants. Chinese hamster ovary (CHO) cells were transiently co-transfected with wild-type (WT) and/or variant KCND3 and Kcnip2. Transient outward potassium currents (Ito) were recorded using the whole-cell patch-clamp method. The inhibitory effect of quinidine on Ito was evaluated. In electrophysiological analysis, CHO cells expressing the variant channels showed a significant increase in current density compared with those expressing WT channels. The Ito activation curves were shifted significantly to the left, and significantly slower inactivation time constants were observed in both variant channels. Recovery from inactivation of the variant channels was significantly slower than that of WT. Quinidine suppressed Ito in a concentration-dependent manner and accelerated the slow inactivation of variant channels. In conclusion, de novo KCND3 variants identified in patients with RE and neurodevelopmental disorders showed gain and loss of function effects on Ito. These patients may be at risk of developing early repolarization syndrome, leading to SUDEP. Increased Ito was suppressed by quinidine, suggesting that it may be an effective therapy for RE and possibly for preventing SUDEP.Keywords
Funding Information
- SENSHIN Medical Research Foundation
- MEXT | Japan Society for the Promotion of Science (22K20906)
- MEXT | Japan Society for the Promotion of Science (24K19074)
- MEXT | Japan Society for the Promotion of Science (19K17593)
This publication has 32 references indexed in Scilit:
- Activation and closed-state inactivation mechanisms of the human voltage-gated KV4 channel complexesMolecular Cell, 2022
- Structural basis for the gating modulation of Kv4.3 by auxiliary subunitsCell Research, 2022
- Structural basis of gating modulation of Kv4 channel complexesNature, 2021
- A de novo gain-of-function KCND3 mutation in early repolarization syndromeHeart Rhythm, 2019
- Novel SCA19/22‐associated KCND3 mutations disrupt human K V 4.3 protein biosynthesis and channel gatingHuman Mutation, 2019
- Novel mutations in the KCND3-encoded Kv4.3 K+ channel associated with autopsy-negative sudden unexplained deathHuman Mutation, 2012
- Transient outward current (Ito) gain-of-function mutations in the KCND3-encoded Kv4.3 potassium channel and Brugada syndromeHeart Rhythm, 2011
- Molecular determinants of cardiac transient outward potassium current (Ito) expression and regulationJournal of Molecular and Cellular Cardiology, 2010
- Structural basis for modulation of Kv4 K+ channels by auxiliary KChIP subunitsNature Neuroscience, 2006
- Gene Structures and Expression Profiles of Three Human KCND (Kv4) Potassium Channels Mediating A-Type Currents ITO and ISAGenomics, 2000